Avantor, Inc.
Every calculator, already run for AVTR
Open the full toolkit →You have the numbers on AVTR. Get the argument.
A written report on which of these readings actually decide the outcome for Avantor, Inc., what has to stay true for the price to work, and the specific thing that would break it. The first one is free.
Key market data
Analyst consensus
16 analysts covering AVTRAnalyst Price Target Disagreement for Avantor, Inc.
Wall Street's bull case implies +38% from the current price; the bear case implies -13%. A 51% spread signals high analyst disagreement — run your own DCF to anchor on fundamentals rather than street consensus.
Ownership & short interest
About Avantor, Inc.
Avantor, Inc. engages in the provision of mission-critical products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, clinical trial kits, and fluid handling tips. It also provides equipment and instrumentation products, including filtration s…
AVTR — frequently asked
Is AVTR a buy right now?
Wall Street's consensus rating on Avantor, Inc. is Hold across 16 analysts, with a mean price target of $14.56 (+6% vs. the current $13.80). Ratings are a starting point — run the DCF and check the financial-health readings above before deciding.
Is AVTR overvalued?
AVTR trades at — trailing earnings, against a DCF fair value of $19 per share. The current price implies 2% annual free-cash-flow growth for a decade. Open the DCF or reverse-DCF tool to change the assumptions and see the range.
When is AVTR's next earnings date?
Avantor, Inc. is next scheduled to report earnings around Oct 28, 2026. A full AVTR research report from Basis Report covers the setup into that print — estimates, the beat/miss record, and what would move the thesis.
What is the analyst price target disagreement for Avantor, Inc.?
Analysts covering Avantor, Inc. (AVTR) range from a bear-case target of $12.00 to a bull-case high of $19.00, with a mean consensus target of $14.56 across 14 analysts. The spread of $7.00 (51% of the current price) indicates high disagreement on the outlook. Run the DCF calculator to build your own estimate independent of street consensus.
Compare Avantor, Inc. against related stocks
Explore additional stock overview pages and jump directly into full report generation for each symbol.
Sector peers
Most-followed names in the same sector.
Nearby tickers
Additional public equities from our tracked universe.
Market leaders
Large-cap symbols investors frequently compare.
Investor Guides For Avantor, Inc.
Start with the evergreen guides that matter most for Healthcare, then move back into the ticker page when you want to pressure-test the framework on a live name.
Generate your full AVTR research report
DCF model, five-year financials, moat assessment, a BUY/HOLD/SELL rating, and the risks that matter — on Avantor, Inc., in minutes. 3 free reports included with every account — no credit card required.